Perrigo Company plc (PRGO) P/E Ratio History
Deep ValueTrading at -1.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 1992–2023
Loading P/E history...
P/E Ratio Analysis
As of June 21, 2026, Perrigo Company plc (PRGO) trades at a price-to-earnings ratio of -1.0x, with a stock price of $10.25 and trailing twelve-month earnings per share of $-13.10.
The current P/E is 101% below its 5-year average of 98.2x. Over the past five years, PRGO's P/E has ranged from a low of 30.4x to a high of 439.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, PRGO trades at a 105% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, PRGO trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PRGO DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PRGO Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
PRGO P/E vs Peers
Consumer health and OTC self-care peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $40B | 18.8 | 2.23Best | +13% | |
| $2B | 12.0Lowest | 3.19 | -9% | |
| $37B | 26.2 | - | +183%Best | |
| $5B | 73.7 | - | +158% | |
| $2B | 52.4 | - | +120% | |
| $90B | 19.6 | - | +49% | |
| $52B | 34.4 | - | +87% | |
| $125B | 70.7 | - | -62% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
PRGO Historical P/E Data (1992–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q3 | Sep 30 2023 | $31.95 | $0.07 | 439.5x | +869% |
| FY2020 Q2 | Jun 27 2020 | $53.94 | $1.74 | 31.0x | -32% |
| FY2020 Q1 | Mar 28 2020 | $46.10 | $1.37 | 33.6x | -26% |
| FY2019 Q4 | - | $51.66 | $1.07 | 48.3x | +6% |
| FY2019 Q3 | Sep 28 2019 | $54.98 | $1.81 | 30.4x | -33% |
| FY2019 Q2 | Jun 29 2019 | $47.62 | $0.65 | 73.3x | +61% |
| FY2019 Q1 | Mar 30 2019 | $48.16 | $0.84 | 57.3x | +26% |
| FY2018 Q4 | Dec 31 2018 | $38.75 | $0.94 | 41.2x | -9% |
| FY2018 Q3 | Sep 29 2018 | $70.80 | $0.86 | 82.3x | +81% |
| FY2018 Q2 | Jun 30 2018 | $72.91 | $1.66 | 43.9x | -3% |
| FY2018 Q1 | Mar 31 2018 | $83.34 | $0.91 | 91.6x | +102% |
| FY2017 Q4 | Dec 31 2017 | $87.16 | $0.84 | 103.8x | +129% |
| FY2015 Q3 | Sep 26 2015 | $160.90 | $0.99 | 162.5x | +258% |
| FY2015 Q2 | Jun 27 2015 | $190.55 | $0.94 | 202.7x | +347% |
| FY2015 Q1 | Mar 28 2015 | $165.97 | $1.54 | 107.8x | +138% |
| FY2014 Q4 | Dec 27 2014 | $165.96 | $2.57 | 64.6x | +42% |
| FY2014 Q3 | Sep 27 2014 | $150.72 | $1.19 | 126.7x | +179% |
| FY2014 Q2 | Jun 28 2014 | $145.97 | $1.65 | 88.5x | +95% |
| FY2014 Q1 | Mar 29 2014 | $153.16 | $1.93 | 79.4x | +75% |
| FY2013 Q4 | Dec 28 2013 | $152.12 | $2.75 | 55.3x | +22% |
| FY2013 Q3 | Sep 28 2013 | $123.70 | $4.74 | 26.1x | -42% |
| FY2013 Q2 | Jun 30 2013 | $121.00 | $4.68 | 25.9x | -43% |
| FY2013 Q1 | Mar 31 2013 | $118.74 | $4.66 | 25.5x | -44% |
| FY2012 Q4 | Dec 31 2012 | $104.03 | $4.71 | 22.1x | -51% |
| FY2012 Q3 | Sep 30 2012 | $116.17 | $4.65 | 25.0x | -45% |
| FY2012 Q2 | Jun 30 2012 | $117.93 | $4.28 | 27.6x | -39% |
| FY2012 Q1 | Mar 31 2012 | $103.31 | $3.97 | 26.0x | -43% |
| FY2011 Q4 | Dec 31 2011 | $97.30 | $3.69 | 26.4x | -42% |
| FY2011 Q3 | Sep 30 2011 | $97.11 | $3.60 | 27.0x | -41% |
| FY2011 Q2 | - | $87.87 | $3.65 | 24.1x | -47% |
| FY2011 Q1 | - | $79.52 | $3.26 | 24.4x | -46% |
| FY2010 Q4 | Dec 31 2010 | $63.33 | $2.98 | 21.3x | -53% |
| FY2010 Q3 | - | $64.22 | $2.66 | 24.1x | -47% |
| FY2010 Q2 | Jun 30 2010 | $59.07 | $2.42 | 24.4x | -46% |
| FY2010 Q1 | Mar 31 2010 | $58.72 | $2.26 | 26.0x | -43% |
| FY2009 Q4 | - | $39.83 | $2.08 | 19.1x | -58% |
| FY2009 Q3 | Sep 30 2009 | $33.99 | $1.70 | 20.0x | -56% |
| FY2009 Q2 | - | $27.78 | $1.54 | 18.0x | -60% |
| FY2009 Q1 | - | $24.83 | $1.46 | 17.0x | -63% |
| FY2008 Q4 | Dec 31 2008 | $32.31 | $1.39 | 23.2x | -49% |
| FY2008 Q3 | - | $38.46 | $1.48 | 26.0x | -43% |
| FY2008 Q2 | Jun 30 2008 | $31.77 | $1.44 | 22.1x | -51% |
| FY2008 Q1 | Mar 31 2008 | $37.73 | $1.34 | 28.2x | -38% |
| FY2007 Q4 | Dec 31 2007 | $35.01 | $1.10 | 31.8x | -30% |
| FY2007 Q3 | Sep 30 2007 | $21.35 | $0.97 | 22.0x | -51% |
| FY2007 Q2 | Jun 30 2007 | $19.58 | $0.79 | 24.8x | -45% |
| FY2007 Q1 | Mar 31 2007 | $17.66 | $0.72 | 24.5x | -46% |
| FY2006 Q4 | Dec 31 2006 | $17.30 | $0.76 | 22.8x | -50% |
| FY2006 Q3 | Sep 30 2006 | $16.97 | $0.80 | 21.2x | -53% |
| FY2006 Q2 | Jun 30 2006 | $16.10 | $0.76 | 21.2x | -53% |
| FY2006 Q1 | Mar 31 2006 | $16.31 | $0.54 | 30.5x | -33% |
| FY2004 Q4 | Dec 31 2004 | $17.27 | $0.82 | 21.1x | -54% |
| FY2004 Q3 | - | $20.55 | $1.13 | 18.2x | -60% |
| FY2004 Q2 | Jun 30 2004 | $18.97 | $1.12 | 16.9x | -63% |
| FY2004 Q1 | Mar 31 2004 | $20.05 | $1.06 | 18.9x | -58% |
| FY2003 Q4 | Dec 31 2003 | $15.72 | $1.02 | 15.4x | -66% |
| FY2003 Q3 | - | $12.73 | $0.73 | 17.4x | -62% |
| FY2003 Q2 | Jun 30 2003 | $15.64 | $0.78 | 20.0x | -56% |
| FY2003 Q1 | Mar 31 2003 | $11.88 | $0.74 | 16.1x | -64% |
| FY2002 Q4 | - | $12.15 | $0.78 | 15.6x | -66% |
| FY2002 Q3 | Sep 30 2002 | $10.63 | $0.74 | 14.4x | -68% |
| FY2002 Q2 | Jun 30 2002 | $13.00 | $0.63 | 20.7x | -54% |
| FY2002 Q1 | Mar 31 2002 | $11.95 | $0.70 | 17.2x | -62% |
| FY2001 Q4 | Dec 31 2001 | $11.82 | $0.60 | 19.8x | -56% |
| FY2001 Q3 | Sep 30 2001 | $15.15 | $0.41 | 37.3x | -18% |
| FY2001 Q2 | Jun 30 2001 | $16.69 | $0.38 | 44.4x | -2% |
| FY2001 Q1 | Mar 31 2001 | $9.88 | $0.18 | 54.9x | +21% |
| FY2000 Q4 | Dec 31 2000 | $8.28 | $0.13 | 63.7x | +40% |
| FY2000 Q3 | Sep 30 2000 | $6.84 | $0.27 | 25.3x | -44% |
| FY2000 Q2 | Jun 30 2000 | $6.31 | $0.27 | 23.4x | -48% |
| FY2000 Q1 | Mar 31 2000 | $7.59 | $0.34 | 22.3x | -51% |
| FY1999 Q4 | Dec 31 1999 | $8.00 | $0.38 | 21.1x | -54% |
| FY1999 Q3 | - | $7.88 | $0.33 | 23.9x | -47% |
| FY1999 Q2 | Jun 30 1999 | $7.63 | $0.02 | 385.4x | +749% |
| FY1998 Q1 | - | $12.25 | $0.58 | 21.1x | -53% |
| FY1997 Q4 | Dec 31 1997 | $13.38 | $0.60 | 22.3x | -51% |
| FY1997 Q3 | - | $15.75 | $0.59 | 26.7x | -41% |
| FY1997 Q2 | Jun 30 1997 | $12.50 | $0.59 | 21.2x | -53% |
| FY1997 Q1 | Mar 31 1997 | $10.88 | $0.53 | 20.4x | -55% |
| FY1996 Q4 | - | $9.13 | $0.52 | 17.4x | -62% |
| FY1996 Q3 | Sep 30 1996 | $9.88 | $0.50 | 19.6x | -57% |
| FY1996 Q2 | Jun 30 1996 | $11.25 | $0.52 | 21.5x | -53% |
| FY1996 Q1 | Mar 31 1996 | $13.50 | $0.53 | 25.4x | -44% |
| FY1995 Q4 | Dec 31 1995 | $11.88 | $0.54 | 22.0x | -52% |
| FY1995 Q3 | Sep 30 1995 | $12.25 | $0.55 | 22.2x | -51% |
| FY1995 Q2 | Jun 30 1995 | $11.06 | $0.58 | 19.0x | -58% |
| FY1995 Q1 | Mar 31 1995 | $11.63 | $0.66 | 17.6x | -61% |
| FY1994 Q4 | Dec 31 1994 | $12.50 | $0.68 | 18.4x | -59% |
| FY1994 Q3 | Sep 30 1994 | $13.50 | $0.71 | 19.0x | -58% |
| FY1994 Q2 | - | $13.75 | $0.71 | 19.4x | -57% |
| FY1994 Q1 | - | $22.50 | $0.71 | 31.7x | -30% |
| FY1993 Q4 | Dec 31 1993 | $34.25 | $0.69 | 49.6x | +9% |
| FY1993 Q3 | - | $31.00 | $0.64 | 48.4x | +7% |
| FY1993 Q2 | Jun 30 1993 | $43.63 | $0.59 | 73.9x | +63% |
| FY1993 Q1 | Mar 31 1993 | $44.75 | $0.54 | 82.9x | +83% |
| FY1992 Q4 | - | $45.00 | $0.50 | 90.0x | +98% |
Average P/E for displayed period: 45.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
34+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PRGO — Frequently Asked Questions
Quick answers to the most common questions about buying PRGO stock.
What is PRGO's P/E ratio?
Perrigo Company plc (PRGO) trailing twelve-month P/E ratio is -1.0x, based on TTM diluted EPS of $-13.10. The 5-year average P/E is 98.2x and the historical range spans 30.4x to 439.5x.
Is PRGO stock overvalued or undervalued?
PRGO trades at -1.0x P/E, below its 5-year average of 98.2x. At the 0th percentile of its historical range (30.4x–439.5x), the stock is priced at a discount to its own history.
Is PRGO stock expensive?
No, PRGO is not expensive on a historical basis. The current P/E of -1.0x is below the 5-year average of 98.2x and sits at the 0th percentile of its valuation range.
What is PRGO's historical P/E range?
Over the past 5 years, PRGO's P/E ratio has ranged from 30.4x to 439.5x, with a median of 79.4x and an average of 98.2x. The current P/E of -1.0x places the stock at the 0th percentile of this range. Full historical data spans 1992–2023.
How does PRGO's P/E compare to the S&P 500?
PRGO trades at -1.0x P/E versus the S&P 500 median of 24.4x. The 104% discount to the market suggests lower growth expectations or perceived higher risk.
How does PRGO's valuation compare to Healthcare peers?
Perrigo Company plc P/E of -1.0x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is PRGO's PEG ratio?
PRGO PEG ratio is N/A, based on a P/E of -1.0x and EPS growth of -723.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is PRGO's earnings yield?
PRGO earnings yield is N/A, the inverse of its -1.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.